148 related articles for article (PubMed ID: 23320394)
1. The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance.
Ehrhardt C; Rückle A; Hrincius ER; Haasbach E; Anhlan D; Ahmann K; Banning C; Reiling SJ; Kühn J; Strobl S; Vitt D; Leban J; Planz O; Ludwig S
Cell Microbiol; 2013 Jul; 15(7):1198-211. PubMed ID: 23320394
[TBL] [Abstract][Full Text] [Related]
2. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus.
Haasbach E; Reiling SJ; Ehrhardt C; Droebner K; Rückle A; Hrincius ER; Leban J; Strobl S; Vitt D; Ludwig S; Planz O
Antiviral Res; 2013 Sep; 99(3):336-44. PubMed ID: 23811282
[TBL] [Abstract][Full Text] [Related]
3. Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity.
Mazur I; Wurzer WJ; Ehrhardt C; Pleschka S; Puthavathana P; Silberzahn T; Wolff T; Planz O; Ludwig S
Cell Microbiol; 2007 Jul; 9(7):1683-94. PubMed ID: 17324159
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Haasbach E; Pauli EK; Spranger R; Mitzner D; Schubert U; Kircheis R; Planz O
Antiviral Res; 2011 Sep; 91(3):304-13. PubMed ID: 21777621
[TBL] [Abstract][Full Text] [Related]
5. Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells.
Sithisarn P; Michaelis M; Schubert-Zsilavecz M; Cinatl J
Antiviral Res; 2013 Jan; 97(1):41-8. PubMed ID: 23098745
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo.
Pinto R; Herold S; Cakarova L; Hoegner K; Lohmeyer J; Planz O; Pleschka S
Antiviral Res; 2011 Oct; 92(1):45-56. PubMed ID: 21641936
[TBL] [Abstract][Full Text] [Related]
7. N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus.
Geiler J; Michaelis M; Naczk P; Leutz A; Langer K; Doerr HW; Cinatl J
Biochem Pharmacol; 2010 Feb; 79(3):413-20. PubMed ID: 19732754
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides targeting the RNA binding region of the NP gene inhibit replication of highly pathogenic avian influenza virus H5N1.
Zhang T; Wang TC; Zhao PS; Liang M; Gao YW; Yang ST; Qin C; Wang CY; Xia XZ
Int Immunopharmacol; 2011 Dec; 11(12):2057-61. PubMed ID: 21933722
[TBL] [Abstract][Full Text] [Related]
9. Infection of human retinal pigment epithelial cells with influenza A viruses.
Michaelis M; Geiler J; Klassert D; Doerr HW; Cinatl J
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5419-25. PubMed ID: 19553611
[TBL] [Abstract][Full Text] [Related]
10. Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.
Perwitasari O; Johnson S; Yan X; Howerth E; Shacham S; Landesman Y; Baloglu E; McCauley D; Tamir S; Tompkins SM; Tripp RA
J Virol; 2014 Sep; 88(17):10228-43. PubMed ID: 24965445
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of influenza virus replication by plant-derived isoquercetin.
Kim Y; Narayanan S; Chang KO
Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo.
Droebner K; Pleschka S; Ludwig S; Planz O
Antiviral Res; 2011 Nov; 92(2):195-203. PubMed ID: 21854809
[TBL] [Abstract][Full Text] [Related]
13. Saikosaponin A inhibits influenza A virus replication and lung immunopathology.
Chen J; Duan M; Zhao Y; Ling F; Xiao K; Li Q; Li B; Lu C; Qi W; Zeng Z; Liao M; Liu Y; Chen W
Oncotarget; 2015 Dec; 6(40):42541-56. PubMed ID: 26637810
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin A1 inhibits avian influenza virus replication at a postentry level: Effect on virus protein synthesis and NF-κB activity.
Carta S; La Frazia S; Donatelli I; Puzelli S; Rossi A; Santoro MG
Prostaglandins Leukot Essent Fatty Acids; 2014 Dec; 91(6):311-23. PubMed ID: 25151089
[TBL] [Abstract][Full Text] [Related]
15. 14-Deoxy-11,12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes.
Cai W; Li Y; Chen S; Wang M; Zhang A; Zhou H; Chen H; Jin M
Antiviral Res; 2015 Jun; 118():82-92. PubMed ID: 25800824
[TBL] [Abstract][Full Text] [Related]
16. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis.
Murray JL; McDonald NJ; Sheng J; Shaw MW; Hodge TW; Rubin DH; O'Brien WA; Smee DF
Antivir Chem Chemother; 2012 May; 22(5):205-15. PubMed ID: 22374988
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligonucleotide inhibits avian influenza virus H5N1 replication by single chain antibody delivery system.
Zhang T; Zhao PS; Zhang W; Liang M; Gao YW; Yang ST; Wang TC; Qin C; Wang CY; Xia XZ
Vaccine; 2011 Feb; 29(8):1558-64. PubMed ID: 21215341
[TBL] [Abstract][Full Text] [Related]
19. Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses.
Park S; Kim JI; Lee I; Lee S; Hwang MW; Bae JY; Heo J; Kim D; Han SZ; Park MS
Biochem Biophys Res Commun; 2013 Oct; 440(1):14-9. PubMed ID: 24012672
[TBL] [Abstract][Full Text] [Related]
20. Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.
Hsieh CF; Lo CW; Liu CH; Lin S; Yen HR; Lin TY; Horng JT
J Ethnopharmacol; 2012 Aug; 143(1):57-67. PubMed ID: 22710290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
